| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |